Skip to content

Observation on the immediate effect of opposing needling Shaoyang acupoints in the treatment of migraine during acute attack

Observation on the immediate effect of opposing needling Shaoyang acupoints in the treatment of migraine during acute attack

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066976
Enrollment
Unknown
Registered
2022-12-22
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Experimental group:acupuncture
Control group:Sham acupuncture

Sponsors

Second Affiliated Hospital of Yunnan University/ School of Acupuncture and Massage-Rehabilitation/ The Second Affiliated Hospital, Yunnan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)Unilateral migraine, male and female, between 18 and 60 years old;(2)Meet the diagnostic criteria of migraine without aura in the International Classification of Headache Disorders ICHD-3 developed by the International Headache Society (IHS) in 2018; (3)Headache attacks of moderate to severe severity (VAS score 4-9);(4)Experiencing acute migraine attacks;(5)Those who volunteered to participate and signed the informed consent form. Note: Patients who meet the above 5 items at the same time may be included in this study.

Exclusion criteria

Exclusion criteria: (1)Patients with bilateral or alternating unilateral migraine;(2) With a history of any trauma to the head, the concomitant headache of another type, or headache of unknown diagnosis;(3) There were serious primary diseases of cardiovascular and cerebrovascular, liver, kidney, hematopoietic system, and other organic diseases;(4) Combined with severe anxiety, depression, insomnia, and other mental diseases or intellectual disability, unable to cooperate with the questionnaire, or infection, bleeding disorders, allergies, skin diseases, etc;(5) Patients who have already taken analgesic medication;(6) Pregnant or breastfeeding patients;(7) Participating in other similar studies. (Note: Patients meeting any of the above criteria will be excluded)

Design outcomes

Primary

MeasureTime frame
Analgesic efficiency at 10 minutes;

Secondary

MeasureTime frame
Analgesic efficiency at1,2,4,6,8,10min;Visual analog scale score (VAS);Evaluation of compliance;Evaluation of blinded success or failure;

Countries

China

Contacts

Public ContactGuo Taipin

Yunnan University of Chinese Medicine

gtphncs@126.com+86 18487272658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026